Pieris Pharmaceuticals Inc (PIRS)
16.98
+0.11
(+0.65%)
USD |
NASDAQ |
Oct 31, 16:00
17.20
+0.22
(+1.30%)
After-Hours: 20:00
Pieris Pharmaceuticals Cash from Investing (Quarterly): 2.176M for June 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 2.176M |
| March 31, 2024 | 9.00M |
| December 31, 2023 | 3.449M |
| September 30, 2023 | -1.984M |
| June 30, 2023 | -1.366M |
| March 31, 2023 | 11.90M |
| December 31, 2022 | 1.107M |
| September 30, 2022 | 5.47M |
| June 30, 2022 | -10.86M |
| March 31, 2022 | -16.95M |
| December 31, 2021 | -0.342M |
| September 30, 2021 | -0.35M |
| June 30, 2021 | -0.229M |
| March 31, 2021 | -0.028M |
| December 31, 2020 | 14.85M |
| September 30, 2020 | 18.35M |
| June 30, 2020 | 5.596M |
| March 31, 2020 | 0.414M |
| December 31, 2019 | -1.881M |
| September 30, 2019 | 4.123M |
| June 30, 2019 | 12.91M |
| March 31, 2019 | -5.316M |
| Date | Value |
|---|---|
| December 31, 2018 | -5.217M |
| September 30, 2018 | 53.40M |
| June 30, 2018 | -48.76M |
| March 31, 2018 | -8.293M |
| December 31, 2017 | -44.74M |
| September 30, 2017 | -0.289M |
| June 30, 2017 | -0.663M |
| March 31, 2017 | -0.179M |
| December 31, 2016 | -0.2373M |
| September 30, 2016 | -0.1981M |
| June 30, 2016 | -0.0567M |
| March 31, 2016 | -0.0679M |
| December 31, 2015 | -0.3515M |
| September 30, 2015 | -0.195M |
| June 30, 2015 | -0.0336M |
| March 31, 2015 | -0.0406M |
| September 30, 2014 | 0.00 |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-16.95M
Minimum
Mar 2022
18.35M
Maximum
Sep 2020
2.017M
Average
0.414M
Median
Mar 2020
Cash from Investing (Quarterly) Benchmarks
| Ligand Pharmaceuticals Inc | -54.76M |
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | -0.0049M |
| iBio Inc | -0.144M |
| Theriva Biologics Inc | -0.001M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.48M |
| Free Cash Flow | -37.87M |
| Free Cash Flow Per Share (Quarterly) | -1.139 |
| Free Cash Flow Yield | -175.8% |